000185208 001__ 185208
000185208 005__ 20181203023035.0
000185208 0247_ $$2doi$$a10.1039/c2dt31936e
000185208 022__ $$a1477-9226
000185208 02470 $$2ISI$$a000313804200002
000185208 037__ $$aARTICLE
000185208 245__ $$aOrganometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death
000185208 260__ $$bRoyal Society of Chemistry$$c2013$$aCambridge
000185208 269__ $$a2013
000185208 300__ $$a4
000185208 336__ $$aJournal Articles
000185208 520__ $$aTwo hybrid compounds comprising an antimetastatic rutheniumarene fragment tethered to an indazole-3-carboxylic acid derivative that inhibits aerobic glycolysis in cancer cells have been prepared and evaluated in a variety of cancer cell lines, including highly relevant human glioblastoma cells, with an apparent synergistic action between the two components observed.
000185208 700__ $$0242063$$g182952$$aNazarov, A.
000185208 700__ $$aGardini, D.
000185208 700__ $$aBaquié, M.
000185208 700__ $$aJuillerat-Jeanneret, L.
000185208 700__ $$aSerkova, T. P.
000185208 700__ $$aShevtsova, E. P.
000185208 700__ $$0240189$$g148592$$aScopelliti, R.
000185208 700__ $$aDyson, Paul Joseph$$g149418$$0240015
000185208 773__ $$j42$$tDalton Transactions$$q2347-2350
000185208 909C0 $$xU9$$0252010$$pLCOM
000185208 909CO $$pSB$$particle$$ooai:infoscience.tind.io:185208
000185208 917Z8 $$x206670
000185208 937__ $$aEPFL-ARTICLE-185208
000185208 973__ $$rREVIEWED$$sPUBLISHED$$aEPFL
000185208 980__ $$aARTICLE